Or browse to enjoy free content and tools. If you would like to add a product to your formulary that is currently not featured on WoundReference, please contact editors@woundreference.com, so that our editorial team can do the research for you and add the product to the. 0000054493 00000 n
A group of district nurses, practice nurses, tissue viability nurses (TVN), clinical management and members of the Medicine Optimisation Team (MOT) have selected the dressings for the Wound Care Formulary. These leaders are the ones who will create engagement, change practice and lead the team when creating the formulary and directly improve patient care by driving clinical practice decision making. The wound care formulary has been developed to reduce unwanted variation and cost. 4 0 obj
While Free Basic members can follow the steps described in this topic to set up and manage their formularies, PRO+HBO and PRO members benefit from full hands-on guidance from our specialists and advisory panel on creation, implementation and maintenance of their digital formularies. The table below illustrates examples of product types needed in each case: Do clinicians at your facility have preferences? Hydrofilm) may be appropriate. . Set up a Formulary User within WoundReference (see, Find out what products your service currently has in stock, Go through the supply room and group all wound care products already available, by brand and size, Establish an approval system for ordering products that are not on formulary, If desired: make a copy of this Google Form ", Work with your product supplier or distributor. Wales NHS, UK Wound Dressing Formulary [Online]. Sorry, this content is only available to registered members. Additionally, the patient perceives the wound team as a cohesive unit and is less confused about current treatment. Click on the following link to access the Gloucestershire Wound Management Formulary. - November, 2021, When and How to Perform Wound Cultures | Engaging Your Patients | Hyperbaric Category A Credits - September, 2021, How to Screen, Assess and Manage Nutrition in Patients with Chronic Wounds - June, 2021, How Safe Is Your Hyperbaric Program? endobj
Includes approved dressings and appliances. This formulary will assist clinical staff in a variety of settings including GP Practices, nursing homes . Intra-uterine progestogen-only device, 7.3.6 Delaying Menstruation During Holidays, 7.4.1 Drugs for voiding (obstructive) symptoms in men, 7.4.2 Drugs for urinary frequency, enuresis, and incontinence, 8.0 Malignant Disease and Immunosuppression, 9.1 Anaemias and some other blood disorders, 9.1.2 Drugs used in megaloblastic anaemias, 9.4.1 Step 1-Identification of nutritional risk, 9.4.2-Step 2-Underlying causes of malnutrition, 9.4.4-Step 4-Discuss Food First dietary advice, Supplementations in pregnancy/ pre-conception, 10.1 Drugs use in rheumatic diseases and gout, 10.1.3 Drugs that suppress the rheumatic disease process, 10.1.4 Gout and cytotoxic-induced hyperuricaemia, 10.1.5 Other drugs for rheumatic diseases, 10.2 Drugs used in neuromuscular disorders, 10.2.1 Drugs that enhance neuromuscular transmission, 10.3 Drugs used for the treatment of soft-tissue disorders and topical pain relief, 10.3.2 Rubefacients, topical NSAIDs, capsaicin, and poultices, 13.2.1.1 Emollient bath and shower preparations, 13.3. Many institutions have binding contracts to obtain tiered discounts on the amount of products purchased, which incentivizes the institution to purchase solely from a specific supplier. 1.1 Dyspepsia and gastro-oesophageal reflux disease (GORD), 1.1.2 Compound alginates and proprietary indigestion preparations, 1.2 Antispasmodics and other drugs altering gut motility, 1.3 Antisecretory drugs and mucosal protectants, 1.5.1.1 Acute Exacerbation of ulcerative colitis, 1.5.1.2 Maintenance of remission of ulcerative colitis, 1.5.2 Corticosteroids inflammatory bowel disease, 1.5.3 Steroid-sparing treatment for inflammatory bowel disease, 1.7 Local preparations for anal and rectal disorders, 1.7.1 Soothing haemorrhoidal preparations, 1.7.2 Compound haemorrhoidal preparations with corticosteroids, 1.9 Drugs affecting intestinal secretions, 2.2.3 Potassium-sparing diuretics and aldosterone antagonists, 2.2.4 Potassium-sparing diuretics with other diuretics, 2.5.2 Centrally acting antihypertensive drugs, 2.5.5 Drugs affecting the renin-angiotensin system, 2.5.5.1 Angiotensin-converting enzyme inhibitors, 2.5.5.2 Angiotensin-II receptor antagonists (AIIRAs/ARBs), 2.6 Nitrates, calcium-channel blockers and other antianginal drugs, 2.6.4 Peripheral vasodilators and related drugs, 2.8.2.2 Treatment of pulmonary embolism and deep vein thrombosis and prevention of recurrent, 2.8.2.3 Prophylaxis of venous thromboembolism in orthopaedics-specialist use in secondary care only, 2.8.2.5 Prevention of Atherothrombotic events, 2.10 Stable angina, acute coronary syndromes and fibrinolysis, 2.11 Antifibrinolytic drugs and haemostatics, 3.1.4 Compound bronchodilator preparations, 3.1.5 Peak flow meters, inhaler devices and nebulisers, 3.2.1 Single agent inhalers [asthma only], 3.2.2 Compound ICS/LABA preparations [asthma], 3.2.3 Compound ICS/LABA preparations COPD, 3.3 Leukotriene receptor antagonists and phosphodiesterase type-4 inhibitors, 3.3.3 Phosphodiesterase type-4 inhibitors, 3.4 Antihistamines, hyposensitisation and allergic emergencies, 3.4.2 Allergen immunotherapy (desensitisation), 4.2 Drugs used in psychoses and related disorders, 4.2.1.1 Management of agitation and aggression, 4.2.3.1 Treatment of the acute phase of mania, 4.2.3.2 Maintenance treatment of bipolar disorder with mood stabilisers, 4.3.1 Mild, moderate and severe depression, 4.3.2 Antidepressants for the treatment of anxiety disorders*, 4.3.2.1 Generalised anxiety disorder (GAD), social anxiety disorder, 4.4 CNS stimulants and drugs used for attention deficit hyperactivity disorder, 4.4.2 Attention deficit hyperactive disorder (ADHD) in adults, 4.5 Drugs used in the treatment of obesity, 4.5.1 Anti-obesity drugs acting on the gastro-intestinal tract, 4.6.1 Drugs for the short-term treatment of nausea and vomiting, 4.7.4.1 Treatment of acute migraine attack, 4.7.4.3 Drug treatment of cluster headache, 4.9 Drugs used in parkinsonism and related disorders, 4.9.1 Dopaminergic drugs used in parkinsonism, 4.9.1.3 Monoamine-oxidase-B (MAOB) inhibitors, 4.9.1.4 Catechol-O-methyltransferase inhibitors (COMT inhibitors), 4.9.2 Antimuscarinic drugs used in parkinsonism, 4.9.4 Management of dementia in Parkinsons disease, 4.10 Medications used in substance use disorders, 4.10.3 Benzodiazepine and Z drug withdrawal, 4.10.4.3 Interventions for the reduction of alcohol consumption, 4.11.1 Management of Behavioural and Psychological Symptoms of Dementia (BPSD), 6.1.2.3 Dipeptidyl peptidase-4 inhibitors (DPP-4 inhibitors), 6.1.2.5 Sodium-glucose co-transporter 2 (SGLT-2) inhibitors, 6.1.6 Diagnostic and monitoring agents for diabetes mellitus, Summary of oral drug treatments for type 2 diabetes, 6.2 Thyroid and antithyroid drugs and parathyroid disease, 6.4.1.1 Hormone replacement therapy (HRT) for menopausal symptoms, 6.4.1.1a Women who have not had a hysterectomy, 6.4.1.1b Women who have had a hysterectomy or who have a Mirena Intra Uterine System (ISU) in situ, 6.5 Pituitary hormones and anti-oestrogens, 6.5.2 Posterior pituitary hormones and antagonists, 6.5.2.2 Antidiuretic hormone antagonists, 6.6.1 Drugs for the treatment and management of osteoporosis, 6.6.1.3 Other drug therapies used in osteoporosis, 7.0 Contraception, Gynaecology and Urinary Tract Disorders, 7.1.3 Endometriosis (previously diagnosed by laparoscopy), 7.2 Treatment of vaginal and vulval conditions, 7.2.1 Preparations for vaginal and vulval changes, Review copy of Review copy of 7.2.2 Vaginal and vulval infections, 7.3.1 Combined hormonal oral contraceptives, 7.3.2.1 Oral progestogen-only contraceptives, 7.3.2.2 Parenteral progestogen-only contraceptives, 7.3.2.3. To access this premium feature and more, upgrade to a premium plan today. ##gG%XP /PLlPd$KcBGg00aZd &U%:y <>/Metadata 2891 0 R/ViewerPreferences 2892 0 R>>
Pressure Ulcer/Injury Prevention - Taking the Journey Forward - December, 2022, Lymphedema Assessment And Management Updates | Local Wound Care Formularies Made Easy - August, 2022, Enhanced Coding And Billing Toolkit for HBOT and Wound Care - June, 2022, 5 Tools To Streamline Patient Education In Wound Care and HBOT - April, 2022, Building a Successful Antimicrobial Stewardship Program in Wound Care | HBOT and Wound Care Ongoing Competencies - February, 2022, Limb Preservation: Step-by-Step | Skin Failure or Pressure Injury? 2 0 obj
Costs associated with certain brands, usage patterns etc. A holistic
%PDF-1.4
%
[2], Train clinicians on how to use the formulary and guidelines. Changes to the 2020 formulary Each year in the NHS millions of pounds of savings need to be made. CID: 902 Published: September 2013 Last Review: September 2020 Next Review: September 2023 The information relating to each product isPaper copies of this document should be kept to a minimum and checks made with the electronic version to ensure that the printed version is the most recent. endobj
NHS Grampian Joint Wound Care Formulary Summary Chart (February 2023) Review: October 2024 . NHS Fife: Area Drugs and Therapeutics Committee, Paediatric Primary Care Antibiotic Guidelines, Guidance on the Management of Proven or Suspected Staph. Subscribe to receive the latest Wound Care updates. If your institution does have such a contract, you will need to limit your choices to products the supplier carries. <>
2: Cardiovascular System. Volume 13 - 2022; Volume 12 - 2021; Volume 14-2023; Volume 11 - 2020; Volume 10 - 2019; Volume 9 - 2018; Volume 8 - 2017; Volume 7 - 2016; Volume 6 - 2015; Volume 5 - 2014; Volume 4 - 2013; Volume 3 . For formulary development, focus on more costly items (e.g., cellular and/or tissue products, dressings, etc) instead of relatively inexpensive items (e.g., syringes, gloves, etc). Antimicrobial Octenilin Wound Gel (20 per pack) 20ml pods 350-8975 1 Amber Antimicrobial Prontosan Pods (24 x 40ml pods) 40ml 374-5940 1 Amber . endobj
0000004600 00000 n
not The WoundReference Digital Formulary Module is available in all WoundReference plans, including the Free Basic Plan (see Plans). <>
What features are important for each product type? Evidence based data associated with product usage. stream
Aureus bacteraemia - Hospital setting; Neutropenic sepsis - Antibiotic management 1113 0 obj
<>
endobj
Antibacterial preparations also used systemically, 13.11 Skin cleansers, antiseptics, and desloughing agents, Cost Effective Choices and Switching PILs, Generic Prescribing Newsletters and Exception List, Swallowing Difficulties & Thickening Agents, Allow extra time when ordering your prescription.